How to buy Immutep shares
Own Immutep shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Immutep Limited is a biotechnology business based in Australia. Immutep shares (IMM) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Immutep has a trailing 12-month revenue of around $6.4 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Immutep
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Immutep . Find the share by name or ticker symbol: IMM. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Immutep reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Immutep . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Immutep share priceUse our graph to track the performance of IMM stocks over time.
Immutep shares at a glance
|52-week range||$0.145 - $44.5|
|50-day moving average||$0.5565|
|200-day moving average||$0.4368|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.006|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Immutep stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Immutep price performance over time
|1 week (2021-06-15)||6.40%|
|1 month (2021-05-21)||9.92%|
|3 months (2021-03-22)||77.33%|
|6 months (2020-12-22)||72.73%|
|1 year (2020-06-22)||329.03%|
|2 years (2019-06-21)||-74.24%|
|3 years (2018-06-22)||-78.40%|
|5 years (2016-06-22)||-85.12%|
|Revenue TTM||$6.4 million|
|Gross profit TTM||$-6,656,699|
|Return on assets TTM||-20%|
|Return on equity TTM||-61.68%|
|Market capitalisation||$399 million|
TTM: trailing 12 months
Immutep share dividends
We're not expecting Immutep to pay a dividend over the next 12 months.
Have Immutep 's shares ever split?
Immutep 's shares were split on a 1:10 basis on 4 November 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Immutep shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Immutep shares which in turn could have impacted Immutep 's share price.
Immutep share price volatility
Over the last 12 months, Immutep 's shares have ranged in value from as little as $0.145 up to $44.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Immutep 's is 1.4373. This would suggest that Immutep 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as ?eftilagimod alpha' or ?efti', which is a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer termed AIPAC and in a Phase I combination therapy trial in metastatic melanoma termed TACTI-mel; and is being evaluated as a combination therapy in head and neck squamous cell carcinoma and non-small cell lung carcinoma in a Phase II clinical trial called TACTI-002 and an investigator initiated Phase I trial called INSIGHT in advanced solid tumors. Its other products include IMP761, IMP701 and IMP731, all of which are related to lymphocyte activation gene 3, a gene linked to the regulation of T cells in immune responses. Immutep Limited has partnerships with GlaxoSmithKline, Novartis, CYTLIMIC Inc., INSIGHT, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia.
Frequently asked questions
More guides on Finder
3 Virgin Australia sales to get you 50% off flights + 50% bonus points
Earn extra points for every $1 spent when you book these domestic flights before the end of the financial year.
Prime Day deal: $100 off Sony’s ‘Bose Killing’ Headphones
Get 33% off Sony WH1000XM3 Wireless Noise Cancelling Headphones during Amazon Prime Day 2021. Here's how to get the deal before it disappears.
Amazon Prime Day best book deals for all ages: Up to 55% off
Snap up best-selling reads for the whole family with these great Australian Prime Day offers.
The best Amazon Prime Day phone deals Australia: $600 off
Top offers include 57% off phone accessories, 38% off OPPO and 36% off Nokia.
Amazon Prime Day’s best appliance deals: 49% off De’Longhi, Philips
From air fryers to coffee makers to vacuum cleaners and more, these are the very best appliance deals that Amazon has to offer this Prime Day.
Amazon Prime Day: 75% off these massive beauty brands
Prime Day is your only chance to save big on Olaplex, Maybelline, La-Roche Posay, Calvin Klein fragrances and more.
Best Amazon Prime Day headphone deals: 58% off Sony + heaps more
Top headphone offers include 58% off Sony, 54% off Sennheiser and 45% off Bose.
Prime Day 2021: Up to 40% off tablets from Lenovo, Samsung and Huawei
Prime Day is here – don't miss your chance to save big on these tablets from your favourite tech brands.
Finder Daily Deals: The 5 best deals in Australia today
Today's best Finder Daily deals include: Amazon Prime Day 2021 deals, $270 off Sunbeam coffee machines, $70 off Xbox Series S.
The best Amazon Prime Day deals from Aussie brands: Get 45% off
Here are the Prime Day deals you can feel especially good about shopping.
Ask an Expert